Now showing items 1-3 of 3

    • Cortisol levels in nails and neurocognitive performance in euthymic bipolar I patients and healthy controls 

      Herane Vives, Andrés; Papadopoulos, A.; King, S.; Chang, C. K.; Cheung, E.; Halari, R.; De Angel, V.; Cleare, A.; Young, A. H. (Elsevier, 2015)
    • DES14X3taz: A type i superluminous supernova showing a luminous, rapidlycooling initial pre-peak bump 

      Smith, M.; Sullivan, M.; D'Andrea, C. B.; Castander, F. J.; Casas, R.; Prajs, S.; Papadopoulos, A.; Nichol, R. C.; Karpenka, N. V.; Bernard, S. R.; Brown, P.; Cartier Ugarte, Regis; Cooke, J.; Curtin, C.; Davis, T. M.; Finley, D. A.; Foley, R. J.; Gal Yam, Avishay; Goldstein, D. A.; González Gaitán, Santiago; Gupta, R. R.; Howell, D. A.; Inserra, C.; Kessler, R.; Lidman, C.; Marriner, J.; Nugent, P.; Pritchard, T. A.; Sako, M.; Smartt, S.; Smith, R. C.; Spinka, H.; Thomas, R. C.; Wolf, R. C.; Zenteno, A.; Abbott, T. M.; Benoit Levy, A.; Bertin, E.; Brooks, D.; Buckley Geer, E.; Carnero Rosell, A.; Kind, Carrasco; Carretero, J.; Crocce, M.; Cunha, C. E.; da Costa, L. N.; Desai, S.; Fosalba, P.; Frieman, J.; Gerdes, D. W.; Gruen, D.; Gruendl, R. A.; Marshall, J. L.; Martini, P.; Miller, C. J.; Miquel, R.; Nord, B. B.; Ogando, R.; Plazas, A. A.; Reil, K.; Romer, A. K.; Roodman, A.; Rykoff, E. S.; Sánchez, E.; Scarpine, V.; Schubnell, M.; Sevilla Noarbe, I.; Soares Santos, M.; Sobreira, F.; Suchyta, E.; Swanson, M. E. C.; Tarle, G.; Walker, A. R.; Wester, W. (IOP PUBLISHING LTD, 2016)
      We present DES14X3taz, a new hydrogen-poor superluminous supernova (SLSN-I) discovered by the Dark Energy Survey (DES) supernova program, with additional photometric data provided by the Survey Using DECam for Superluminous ...
    • Inflammation and clinical response to treatment indepression: Ameta-analysis 

      Strawbridge, R.; Arnone, D.; Danese, A.; Papadopoulos, A.; Herane Vives, Andrés; Cleare, A. J. (Elsevier, 2015)
      The depressive state has been characterised as one of elevated inflammation, which holds promise for better understanding treatment-resistance inaffective disorders as well as for future developments in treatment stratification.